Enzymecode Biotechnology Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

Enzymecode Biotechnology General Information

Description

Developer and provider of brain health and other core nutritional raw materials intended to address severe aging problems and improve body functions. The company's raw materials focus on synthetic biology and microstructure process technology to produce high-value ingredients, and their products include phosphatidylserine, high-pressure jet nano, pulverization system and aflatoxin adsorption remover that can be used to improve memory, brain fatigue, stress and sleep and is widely used in functional foods, milk powder and other fields, enabling consumers to leverage highly nutritional materials to improve health via nutritional intervention.

Contact Information

Website
www.enzymecode.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 3, No. 669
  • Zhujiang Road, Binhai New District
  • Tianjin
  • China
+86 186
Primary Industry
Specialty Chemicals
Other Industries
Other Agriculture
Biotechnology
Vertical(s)
AgTech, Life Sciences
Corporate Office
  • Building 3, No. 669
  • Zhujiang Road, Binhai New District
  • Tianjin
  • China
+86 186

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enzymecode Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 02-Jan-2024 Completed Generating Revenue
To view Enzymecode Biotechnology’s complete valuation and funding history, request access »

Enzymecode Biotechnology Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Enzymecode Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021253476-A1 Method for synthesizing beta-nicotinamide mononucleotide and intermediate thereof Inactive 19-Jun-2020

Enzymecode Biotechnology Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
DFJ DragonFund China Venture Capital Minority
Probe Capital Investment Bank Minority
To view Enzymecode Biotechnology’s complete investors history, request access »

Ready to get started?

Request a free trial

Enzymecode Biotechnology FAQs

  • When was Enzymecode Biotechnology founded?

    Enzymecode Biotechnology was founded in 2017.

  • Where is Enzymecode Biotechnology headquartered?

    Enzymecode Biotechnology is headquartered in Tianjin, China.

  • What industry is Enzymecode Biotechnology in?

    Enzymecode Biotechnology’s primary industry is Specialty Chemicals.

  • Is Enzymecode Biotechnology a private or public company?

    Enzymecode Biotechnology is a Private company.

  • What is Enzymecode Biotechnology’s current revenue?

    The current revenue for Enzymecode Biotechnology is .

  • Who are Enzymecode Biotechnology’s investors?

    DFJ DragonFund China and Probe Capital have invested in Enzymecode Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process